CEP41 Protein (Myc-DYKDDDDK Tag)

Produktnummer ABIN2734444

Produktdetails

Target: CEP41 (Centrosomal Protein 41kDa (CEP41))

Protein-Typ: Recombinant

Spezies: Human

Quelle: HEK-293 Cells

Aufreinigungstag / Konjugat: Dieses CEP41 Protein ist gelabelt mit Myc-DYKDDDDK Tag.

Applikation: Antibody Production (AbP), Standard (STD)

Produktmerkmale:

• Recombinant human TSGA14 / CEP41 protein expressed in HEK293 cells.
• Produced with end-sequenced ORF clone

Reinheit: > 80 % as determined by SDS-PAGE and Coomassie blue staining

Anwendungsinformationen

Applikationshinweise: Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays

Kommentare:

The tag is located at the C-terminal.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 50 μg/mL

Buffer: 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.

Lagerung: -80 °C

Informationen zur Lagerung: Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.

Antigendetails

Target: CEP41 (Centrosomal Protein 41kDa (CEP41))

Andere Bezeichnung: Tsga14,cep41 (CEP41 Produkte)

Synonyme: 1700017E11Rik Protein, 2810431D15Rik Protein, AI449046 Protein, AI503610 Protein, Tsga14 Protein, JBTS15 Protein, TSGA14 Protein, Cep41-A Protein, tsga14 Protein, RPL37A Protein, centrosomal protein 41 Protein, centrosomal protein 41kDa S homeolog Protein, Cep41 Protein, CEP41 Protein, cep41.S Protein

Hintergrund: This gene encodes a centrosomal and microtubule-binding protein which is predicted to have two coiled-coil domains and a rhodanese domain. In human retinal pigment epithelial cells the protein localized to centrioles and cilia. Mutations in this gene have been associated with Joubert Syndrome 15 an autosomal recessive ciliopathy and neurological disorder. Alternative splicing results in multiple transcript variants.

Molekulargewicht: 41.2 kDa

NCBI Accession: NP_061188

Pathways: M Phase